492 filings
Page 2 of 25
8-K
vqeca
2 May 23
Dexcom Announces Proposed Offering of $1.0 Billion of Convertible Senior Notes
7:16am
8-K
h4352 8ef
27 Apr 23
Dexcom Reports First Quarter 2023 Financial Results
12:00am
ARS
tvj676ww cpgr6y1rf
6 Apr 23
Annual report to shareholders
4:54pm
DEFA14A
0w0msktpj0mw
6 Apr 23
Additional proxy soliciting materials
4:16pm
8-K
jneh46rhb6ol x02
9 Feb 23
Dexcom Reports Fourth Quarter and Fiscal Year 2022 Financial Results
4:05pm
8-K
3zqysfu08 wk
9 Jan 23
Dexcom Reports Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2022 and Initial 2023 Outlook
8:03am
8-K
w6jgap8tsrly
27 Oct 22
Dexcom Reports Third Quarter 2022 Financial Results
4:05pm
8-K
k45a1koc1nxteu
31 Aug 22
Departure of Directors or Certain Officers
5:01pm
8-K
9u6 gourhu1hzf
5 Aug 22
Other Events
4:52pm
8-K
wenp5puw3kl 77n
28 Jul 22
Other Events
4:23pm
8-K
i83x5f5vz8axz du7e
28 Jul 22
Dexcom Reports Second Quarter 2022 Financial Results
4:07pm
8-K
9q5hjc2yt 506gqen
8 Jul 22
Departure of Directors or Certain Officers
4:30pm
8-K
sv239m0loc
10 Jun 22
Amendments to Articles of Incorporation or Bylaws
4:01pm
SD
0h68t
31 May 22
Conflict minerals disclosure
4:44pm
8-K
ajyy42zqvlu3bu7t0
20 May 22
Submission of Matters to a Vote of Security Holders
9:01am